- 1Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China
- 2Laboratory of Genetic Disease and Perinatal Medicine, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China
- 3Department of Reproductive Medical Center, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China
A Correction on:
The promoter T-413A variant and elevated enzyme levels of heme oxygenase-1 associated with an increased risk of polycystic ovarian syndrome
By Wang Q, Liang J, Liu Q, Liu H, Bai H, Huang W and Fan P (2025) Front. Endocrinol. 16:1644373. doi: 10.3389/fendo.2025.1644373
There were mistakes in Table 2 as published:
i. In the unadjusted OR (95% CI) column, the word ‘Referent’ missed in lines 3 and 18.
ii. Revision of data in the OR value in line 9 from 1.257 to 1.275 and the 95% CI value in last line from (0.950-0.239) to (0.950–1.229).
iii. Revision of data in the OR (95% CI) column, some hyphens from “-” to “–”].
The corrected Table 2 appears below (The red font represents the modified contents).
Table 2. Association of HMOX1 T-413A (rs2071746) and (GT)n repeat polymorphisms with the risk of PCOS using different genetic models.
The original version of this article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: heme oxygenase-1, genetic polymorphism, polycystic ovarian syndrome, oxidative stress, metabolism
Citation: Wang Q, Liang J, Liu Q, Liu H, Bai H, Huang W and Fan P (2026) Correction: The promoter T-413A variant and elevated enzyme levels of heme oxygenase-1 associated with an increased risk of polycystic ovarian syndrome. Front. Endocrinol. 17:1739810. doi: 10.3389/fendo.2026.1739810
Received: 05 November 2025; Accepted: 09 January 2026; Revised: 08 January 2026;
Published: 20 January 2026.
Edited and reviewed by:
Edgar Ricardo Vázquez-Martínez, National Autonomous University of Mexico, MexicoCopyright © 2026 Wang, Liang, Liu, Liu, Bai, Huang and Fan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Wei Huang, d2VpaHVhbmc2NEAxNjMuY29t; Ping Fan , ZmFucGluZzE1QHNjdS5lZHUuY24=
Qingqing Liu2